Viemed Healthcare, Inc.
VMD
$6.88
-$0.16-2.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 254.79M | 240.88M | 232.79M | 224.26M | 214.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 254.79M | 240.88M | 232.79M | 224.26M | 214.30M |
| Cost of Revenue | 107.30M | 100.37M | 96.11M | 91.05M | 85.13M |
| Gross Profit | 147.49M | 140.52M | 136.68M | 133.20M | 129.18M |
| SG&A Expenses | 124.72M | 119.83M | 116.65M | 112.13M | 107.79M |
| Depreciation & Amortization | 1.44M | 1.39M | 1.42M | 1.48M | 1.57M |
| Other Operating Expenses | -279.00K | -511.00K | -776.00K | -727.00K | -613.00K |
| Total Operating Expenses | 236.40M | 224.28M | 216.51M | 207.01M | 196.79M |
| Operating Income | 18.39M | 16.60M | 16.28M | 17.25M | 17.51M |
| Income Before Tax | 20.07M | 20.43M | 17.71M | 16.17M | 14.94M |
| Income Tax Expenses | 6.08M | 6.14M | 5.20M | 4.76M | 4.48M |
| Earnings from Continuing Operations | 13.98 | 14.29 | 12.52 | 11.41 | 10.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -373.00K | -313.00K | -229.00K | -144.00K | -36.00K |
| Net Income | 13.61M | 13.98M | 12.29M | 11.27M | 10.43M |
| EBIT | 18.39M | 16.60M | 16.28M | 17.25M | 17.51M |
| EBITDA | 45.80M | 42.88M | 41.98M | 42.62M | 42.43M |
| EPS Basic | 0.35 | 0.36 | 0.31 | 0.29 | 0.27 |
| Normalized Basic EPS | 0.27 | 0.25 | 0.23 | 0.25 | 0.25 |
| EPS Diluted | 0.34 | 0.35 | 0.31 | 0.29 | 0.26 |
| Normalized Diluted EPS | 0.26 | 0.24 | 0.21 | 0.23 | 0.24 |
| Average Basic Shares Outstanding | 156.61M | 156.84M | 156.15M | 155.44M | 154.90M |
| Average Diluted Shares Outstanding | 164.73M | 165.01M | 164.48M | 163.44M | 162.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |